Results

1–9 of 9 results for exudative age-related macular degeneration

Exudative Age-Related Macular Degeneration Events from the OAKS and DERBY Clinical Trials of Pegcetacoplan in Geographic Atrophy
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2023
Accuracy of Diagnosis Codes for Patients With Concurrent Geographic Atrophy and Exudative Age-Related Macular Degeneration
Jong G Park, MD
Annual Meeting Talks
2023
Charlson Comorbidity Index As a Predictive Tool in Patients With Exudative Age-Related Macular Degeneration in Delay of Care
Vivienne S. Hau, MD, PhD
Annual Meeting Talks
2024
Conversion Rates from Nonexudative to Exudative Age-Related Macular Degeneration: An AAO IRIS® Registry Analysis
Dan A Gong, MD
Annual Meeting Talks
2022
Modifier-25 Examinations Reduce Travel Burden, Decrease Treatment Cost, and Improve QALY for Exudative Age-Related Macular Degeneration Patients
Henry A Leder, MD
Annual Meeting Talks
2020
Ten-Year Follow-Up of Patients With Exudative Age-Related Macular Degeneration Treated With Intravitreal Anti-VEGF Injections
Sophie Jane Bakri, MD
Annual Meeting Talks
2020
Intravitreal Bevacizumab vs. Bevacizumab with Dexamethasone for the Treatment of Exudative Age-Related Macular Degeneration
Reda Issa, MD
On Demand Cases, Courses, and Papers
2019
OCT Angiography (OCTA) and Exudative Age-Related Macular Degeneration (ARMD): Diagnosis, Treatment, and Correlation to IVFA and ICG Videoimaging
Mark H. Nelson, MD, MBA
Annual Meeting Talks
2017
OCT Angiography (OCTA) and Exudative Age-Related Macular Degeneration (ARMD)
Mark H. Nelson, MD, MBA
Updates from the Field
2017